Genomic
Testing
We provide comprehensive tumor genomic
testing to assist in personal treatment
approaches that are recognized as targeted
therapies and immunotherapies.
 Su Series: Pan-Cancer Panel |
|||
| Product | YuanSu | YuanSu S | YuanSu IO |
| Sample Type | FFPE Peripheral whole blood |
FFPE Peripheral whole blood |
FFPE Peripheral whole blood |
| Genes | 600+ | 600+ | 600+ |
| Immunotherapy Biomarker |
TMB/MSI | TMB/MSI | TMB/MSI/PD-L1 |
| Analyte | DNA | DNA+RNA | DNA+Protein (IHC) |
 Yuan Series |
 Zhi Series |
 Ben Series |
|
| Product | QiYuan?ctDNA | ZhiXun WES+ | BenChu Germline Testing |
| Sample Type | Plasma | FFPE Peripheral whole blood |
Peripheral whole blood |
| Genes | 329 | 20,000 | BRCA1/2, PALB2 |
| Immunotherapy Biomarker |
bTMB | TMB/MSI/PD-L1/HLA/TNB | - |
| Analyte | ctDNA | DNA+ Protein (IHC) | DNA |
Validation of Su Series has been accepted by the Oncologist, 2019